Mycophenolate mofetil Active Not Recruiting Phase 2 Trials for Stage III Aggressive Adult Non-Hodgkin Lymphoma / Recurrent Mantle Cell Lymphoma / Childhood Acute Myeloid Leukemia / Stage IV Diffuse Large B-Cell Lymphoma / Adult Diffuse Large B-Cell Lymphoma / Stage I Childhood Hodgkin Lymphoma / Loss of Chromosome 17p / Stage IV Adult Hodgkin Lymphoma / Childhood Chronic Myelogenous Leukemia, BCR-ABL1 Positive / Stage IV Childhood Hodgkin Lymphoma / Stage II Diffuse Large B-Cell Lymphoma / Stage III Chronic Lymphocytic Leukemia / Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive / Stage II Chronic Lymphocytic Leukemia / Stage II Non-Contiguous Mantle Cell Lymphoma / Stage I Aggressive Adult Non-Hodgkin Lymphoma / Stage II Small Lymphocytic Lymphoma / Recurrent Plasma Cell Myeloma / Stage II Adult Hodgkin Lymphoma / T-cell chronic lymphocytic leukaemia / Childhood Diffuse Large B -Cell Lymphoma / Aggressive Non-Hodgkin Lymphoma / Stage II Non-Contiguous Aggressive Adult Non-Hodgkin Lymphoma / Blasts Under 5 Percent of Bone Marrow Nucleated Cells / chronic, recurrent Lymphocytic Leukemia / DS Stage II Plasma Cell Myeloma / Recurrent Diffuse Large B-Cell Lymphoma / aggressive, recurrent Adult Non-Hodgkin Lymphoma / Stage I Mantle Cell Lymphoma / Childhood Acute Lymphoblastic Leukemia / Myelodysplastic/Myeloproliferative Neoplasms / Stage III Adult Hodgkin Lymphoma / Stage II Childhood Hodgkin Lymphoma / Recurrent Hodgkin Lymphoma / Stage IV Mantle Cell Lymphoma / Leukemia, Prolymphocytic / Recurrent Adult Acute Myeloid Leukemia / Stage I Diffuse Large B-Cell Lymphoma / Stage III Mantle Cell Lymphoma / Recurrent Non-Hodgkin Lymphoma / Stage I Adult Hodgkin Lymphoma / Stage I Chronic Lymphocytic Leukemia / Non-Hodgkin's Lymphoma (NHL) / Waldenström's Macroglobulinemia (WM) / Stage III Diffuse Large B-Cell Lymphoma / Chronic Lymphocytic Leukemia (CLL) - Refractory / Recurrent Adult Acute Lymphoblastic Leukemia / DS Stage I Plasma Cell Myeloma / Adult Acute Myeloid Leukemia / T-Cell Prolymphocytic Leukemia / Stage IV Chronic Lymphocytic Leukemia / Recurrent Small Lymphocytic Lymphoma / Recurrent Childhood Acute Lymphoblastic Leukemia / Stage III Childhood Hodgkin Lymphoma / Stage II Contiguous Mantle Cell Lymphoma / Recurrent Childhood Acute Myeloid Leukemia / Chronic Lymphocytic Leukaemia (CLL) / Stage I Small Lymphocytic Lymphoma / Refractory Childhood Hodgkin Lymphoma / Adult Acute Lymphoblastic Leukemia / Stage II Contiguous Adult Aggressive Non-Hodgkin Lymphoma / Stage III Small Lymphocytic Lymphoma / Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive / Stage IV Small Lymphocytic Lymphoma / DS Stage III Plasma Cell Myeloma / Stage IV Aggressive Adult Non-Hodgkin Lymphoma Prevention

IndicationsStatusPurposePhase
Active Not RecruitingPrevention2
clinicaltrials.gov IdentifierTitleDrugs
NCT01527045Donor Atorvastatin Treatment in Preventing Severe Acute GVHD After Nonmyeloablative Peripheral Blood Stem Cell Transplant in Patients With Hematological Malignancies